Search Results - "трансъюгулярное внутрипеченочное портосистемное шунтирование"

1

Academic Journal

Diagnosis and treatment of resistant ascites in liver recipients in the early post-transplant period ; Диагностика и лечение резистентного асцита у реципиентов печени в раннем посттрансплантационном периоде

Authors: K. Yu. Kokina, Ya. G. Moysyuk, Olga V. Sumtsova, A. O. Grigorevskaya, Yu. O. Malinovskaya, Аlexey B. Sidorenko, S. L. Malov, A. V. Azarov, M. S. Kapranov, К. Ю. Кокина, Я. Г. Мойсюк, О. В. Сумцова, А. О. Григоревская, Ю. О. Малиновская, А. Б. Сидоренко, С. Л. Малов, А. В. Азаров, М. С. Капранов

Source: Transplantologiya. The Russian Journal of Transplantation; Том 17, № 1 (2025); 41-55 ; Трансплантология; Том 17, № 1 (2025); 41-55 ; 2542-0909 ; 2074-0506

Subject Terms: синдром синусоидальной обструкции, resistant ascites, splenic artery embolization, transjugular intrahepatic portosystemic shunt, hepatic venous outflow obstruction, arterioportal fistula, veno-occlusive disease, sinusoidal obstruction syndrome, резистентный асцит, эмболизация селезеночной артерии, трансъюгулярное внутрипеченочное портосистемное шунтирование, обструкция печеночного венозного оттока, артериопортальная фистула, венооклюзионная болезнь

File Description: application/pdf

Relation: https://www.jtransplantologiya.ru/jour/article/view/965/927; https://www.jtransplantologiya.ru/jour/article/view/965/934; EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460. PMID: 29653741 https://doi.org/10.1016/j.jhep.2018.03.024; Balcar L, Tonon M, Semmler G, Calvino V, Hartl L, Incicco S, et al. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event. JHEP Rep. 2022;4(8):100513. PMID: 35845294 https://doi.org/10.1016/j.jhepr.2022.100513; Kulkarni R, Thomas E, Zendejas I, Fair J, Andreoni K. Refractory ascites after liver transplantation: a stepwise approach to diagnosis and treatment. Adv Res Gastroentero Hepatol. 2016;2(2):555584. https://doi.org/10.19080/ARGH.2016.02.555584; Mucenic M, Brandao ABM, Marroni CA, Fleck-Junior AM, Zanotelli ML, et al. Persistent ascites after orthotopic liver transplantation: analysis of predictive factors. J Liver. 2018;7(4):000232. https://doi.org/10.4172/2167-0889.1000232; Gotthardt DN, Weiss KH, Rathenberg V, Schemmer P, Stremmel W, Sauer P. Persistent ascites after liver transplantation: etiology, treatment and impact on survival. Ann Transplant. 2013;24(18):378–83. PMID: 23881303 https://doi.org/10.12659/AOT.883982; Al-Zoubi M, Alarabiyat M, Hann A, Mehrzhad H, Karkhanis S, Muiesan P, et al. Management of ascites following deceased donor liver transplantation: a case series. Transplant Direct. 2022;8(8):e1350. PMID: 35923811 https://doi.org/10.1097/TXD.0000000000001350; Jenkins M, Satoskar R. Ascites after liver transplantation. Clin Liver Dis (Hoboken). 2021;17(4):317–319. PMID: 33968396 https://doi.org/10.1002/cld.1050; Ng SS, Yu SC, Lee JF, Lai PB, Lau WY. Hepatic venous outflow obstruction after piggyback liver transplantation by an unusual mechanism: report of a case. World J Gastroenterol. 2006;12(33):5416–8. PMID: 16981282 https://doi.org/10.3748/wjg.v12.i33.5416; Arudchelvam J, Bartlett A, McCall J, Johnston P, Gane E, Munn S. Hepatic venous outflow obstruction in piggyback liver transplantation: single centre experience. ANZ J Surg. 2017;87(3):182–185. PMID: 26471387 https://doi.org/10.1111/ans.13344; Kubo T, Shibata T, Itoh K, Maetani Y, Isoda H, Hiraoka M, et al. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology. 2006;239(1):285–90. PMID: 16567488 https://doi.org/10.1148/radiol.2391050387; Lim C, Osseis M, Tudisco A, Lahat E, Sotirov D, Salloum C, et al. Hepatic venous outflow obstruction after whole liver transplantation of large-for-size graft: versatile intra-operative management. Ann Hepatobiliary Pancreat Surg. 2018;22(4):321–325. PMID: 30588522 https://doi.org/10.14701/ahbps.2018.22.4.321; Viteri-Ramírez G, Alonso-Burgos A, Simon-Yarza I, Rotellar F, Herrero JI, Bilbao JI. Hepatic venous outflow obstruction after transplantation: outcomes for treatment with self-expanding stents. Radiologia. 2015;57(1):56–65. PMID: 24784003 https://doi.org/10.1016/j.rx.2013.09.010; Chong WK, Beland JC, Weeks SM. Sonographic evaluation of venous obstruction in liver transplants. AJR Am J Roentgenol. 2007;188(6):W51521. PMID: 17515341 https://doi.org/10.2214/AJR.06.1262; Kim PH, Yoon HM, Jung AY, Lee JS, Cho YA, Oh SH, et al. Diagnostic accuracy of CT and Doppler US for hepatic outflow obstruction after pediatric liver transplantation using left lobe or left lateral section grafts. Ultrasonography. 2024;43(2):110-120. PMID: 38369738 https://doi.org/10.14366/usg.23190; Monroe EJ, Jeyakumar A, Ingraham CR, Shivaram G, Koo KSH, Hsu EK, et al. Doppler ultrasound predictors of transplant hepatic venous outflow obstruction in pediatric patients. Pediatr Transplant. 2018;22(8):e13310. PMID: 30338622 https://doi.org/10.1111/petr.13310; Pandhi M, Lipnik A, Niemeyer M. Endovascular treatment of hepatic venous outflow obstruction after liver transplant. Dig Dis Interv. 2019;3:277–286. https://doi.org/10.1055/s-0039-3400494. Available at: https://www.thiemeconnect.de/products/ejournals/pdf/10.1055/s-0039-3400494.pdf [Accessed December 26, 2024].; Юдин А.Л., Афукова О.А., Кляншин А.А., Учеваткин А.А. Визуализация застойной гепатопатии. Медицинская визуализация. 2016;(5):59–66. Yudin AL, Afukova OA, Klyanshin AA, Uchevatkin AA. Visualization of congestive hepatopathy. Medical Visualization. 2016;(5):59–66. (In Russ.).; Pitchaimuthu M, Roll GR, Zia Z, Olliff S, Mehrzad H, Hodson J, et al. Long-term follow-up after endovascular treatment of hepatic venous outflow obstruction following liver transplantation. Transpl Int. 2016;29(10):1106– 1116. PMID: 27371935 https://doi.org/10.1111/tri.12817; Nagata R, Akamatsu N, Shibata E, Takao H, Ichida A, Kawaguchi Y, et al. Metallic stents for hepatic venous outflow obstruction after living-donor liver transplantation and their therapeutic effects. Transplant Proc. 2024;56(1):125– 134. PMID: 38177046 https://doi.org/10.1016/j.transproceed.2023.11.009; Chu HH, Yi NJ, Kim HC, Lee KW, Suh KS, Jae HJ, et al. Longterm outcomes of stent placement for hepatic venous outflow obstruction in adult liver transplantation recipients. Liver Transpl. 2016;22(11):1554–1561. PMID: 27516340 https://doi.org/10.1002/lt.24598; Gastaca M, Valdivieso A, Ruiz P, Gonzalez J, Ventoso A, de Urbina JO. Venous outflow obstruction after orthotopic liver transplantation: use of a breast implant to maintain graft position. Clin Transplant. 2011;25(3):E320–326. PMID: 21651618 https://doi.org/10.1111/j.1399-0012.2011.01423.x; Pérez-Sánchez LE, Orti-Rodríguez RJ, Reyes Correa B, Moneva Arce E, Barrera Gómez MÁ. Breast implant during orthotopic liver transplant to avoid hepatic outflow obstruction. Acta Chir Belg. 2020;120(2):146–147. PMID: 31690217 https://doi.org/10.1080/00015458.2019.1689644; Wahab MA, Shehta A, Hamed H, Elshobary M, Salah T, Sultan AM, et al. Hepatic venous outflow obstruction after living donor liver transplantation managed with ectopic placement of a foley catheter: a case report. Int J Surg Case Rep. 2015;10:65–68. PMID: 25805611 https://doi.org/10.1016/j.ijscr.2015.03.017; Fang Y, Moelker A, den Hoed CM, Porte RJ, Minnee RC, Boehnert MU. Outflow obstruction after living donor liver transplantation managed with a temporary vena cava filter: a case report. Int J Surg Case Rep. 2023;112:108981. PMID: 37883875 https://doi.org/10.1016/j.ijscr.2023.108981; Ostojic A, Petrovic I, Silovski H, Kosuta I, Sremac M, Mrzljak A. Approach to persistent ascites after liver transplantation. World J Hepatol. 2022;14(9):1739–1746. PMID: 36185723 https://doi.org/10.4254/wjh.v14.i9.1739; Barrera-Lozano LM, RamírezArbeláez JA, Muñoz CL, Becerra JA, Toro LG, Ardila CM. Portal vein thrombosis in liver transplantation: a retrospective cohort study. J Clin Med. 2023;12(12):3951. PMID: 37373645 https://doi.org/10.3390/jcm12123951; Sambommatsu Y, Shimata K, Ibuki S, Narita Y, Isono K, Honda M, et al. Portal vein complications after adult living donor liver transplantation: time of onset and deformity patterns affect long-term outcomes. Liver Transpl. 2021;27(6):854–865. PMID: 33346927 https://doi.org/10.1002/lt.25977; Schneider N, Scanga A, Stokes L, Perri R. Portal vein stenosis: a rare yet clinically important cause of delayed on set ascites after adult deceased donor liver transplantation: two case reports. Transplant Proc. 2011;43(10):3829– 3834. PMID: 22172855 https://doi.org/10.1016/j.transproceed.2011.09.068; Sare A, Chandra V, Shanmugasundaram S, Shukla PA, Kumar A. Safety and efficacy of endovascular treatment of portal vein stenosis in liver transplant recipients: a systematic review. Vasc Endovascular Surg. 2021;55(5):452– 460. PMID: 33618615 https://doi.org/10.1177/1538574421994417; Новрузбеков М.С., Олисов О.Д. Сосудистые осложнения после ортотопической трансплантации печени. Трансплантология. 2017;9(1):35–50. Novruzbekov MS, Olisov OD. Vascular complications after orthotopic liver transplantation. Transplantologiya. The Russian Journal of Transplantation. 2017;9(1):35–50. (In Russ.). https://doi.org/10.23873/2074-0506-2017-9-1-35-50; Barrera-Lozano LM, RamírezArbeláez JA, Muñoz CL, Becerra JA, Toro LG, Ardila CM. Portal vein thrombosis in liver transplantation. Arq Bras Cir Dig. 2012;25(4):273–8. PMID: 23411928 https://doi.org/10.1590/s0102-67202012000400012; Kim KS, Kim JM, Lee JS, Choi GS, Cho JW, Lee SK. Stent insertion and balloon angioplasty for portal vein stenosis after liver transplantation: long-term follow-up results. Diagn Interv Radiol. 2019;25(3):231–237. PMID: 31063137 https://doi.org/10.5152/dir.2019.18155; Kykalos S, Karatza E, Kotsifa E, Pappas P, Sotiropoulos GC. Portal vein stent placement in anastomotic stenosis after deceased donor liver transplantation: a case report. Transplant Proc. 2021;53(9):2779–2781. PMID: 34593252 https://doi.org/10.1016/j.transproceed.2021.08.035; Saad WE. Arterioportal fistulas in liver transplant recipients. Semin Intervent Radiol. 2012;29(2):105110. PMID: 23729980 https://doi.org/10.1055/s-0032-1312571; Dawkins M, Cheung N, Rozenblit G, Wolf DC. Intrahepatic arterioportal fistula with subsequent portal hypertension after percutaneous liver biopsy. ACG Case Rep J. 2024;11(3):e01287. PMID: 38425943 https://doi.org/10.14309/crj.0000000000001287; Torres Cuevas BL, Castillo Lara GE, Páez Suárez D, Eilers M. Traumatic high flow arterioportal fistula. Correction by a covered stent. Rev Esp Enferm Dig. 2023;115(1):39–40. PMID:35255703 https://doi.org/10.17235/reed.2022.8724/2022; Taher H, Kidr E, Kamal A, ElGobashy M, Mashhour S, Nassef A, et al. Transhepatic ultrasound guided embolization as a successful novel technique in treatment of pediatric complex intrahepatic arterioportal fistula: a case report and review of the literature. J Med Case Rep. 2023;17(1):412. PMID: 37710289 https://doi.org/10.1186/s13256-023-04047-0; Mendoza Quevedo MD, Vaca-Espinosa MC, Marín Zuluaga JI, Amell Baron BC, Vargas AK. Refractory ascites after liver transplantation treated with splenic artery embolization: a case report and literature review. Cureus. 2023;15(8):e43910. PMID: 37746399 https://doi.org/10.7759/cureus.43910; Calderon Novoa F, Mattera J, de Santibañes M, Ardiles V, Gadano A, D'Agostino DE, et al. Understanding local hemodynamic changes after liver transplant: different entities or simply different sides to the same coin? Transplant Direct. 2022;8(9):e1369. PMID: 36313127 https://doi.org/10.1097/TXD.0000000000001369; Saad WE. Nonocclusive hepatic artery hypoperfusion syndrome (splenic steal syndrome) in liver transplant recipients. Semin Intervent Radiol. 2012;29(2):140– 146. PMID: 23729985 https://doi.org/10.1055/s-0032-1312576; Bharathy KG, Shenvi S. Portal Hemodynamics after living-donor liver transplantation: management for optimal graft and patient outcomes – a narrative review. Transplantology. 2023;4(2):38–58. https://doi.org/10.3390/transplantology4020006; Quintini C, D'Amico G, Brown C, Aucejo F, Hashimoto K, Kelly DM, et al. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl. 2011;17(6):668–673. PMID: 21618687 https://doi.org/10.1002/lt.22280; Bloom PP, Gilbert T, SantosParker K, Memel Z, Przybyszewski E, Bethea E, et al. The incidence and natural history of ascites after liver transplantation. Hepatol Commun. 2023;7(6):e0158. PMID: 37219847 https://doi.org/10.1097/HC9.0000000000000158; Lee TB, Yang K, Ko HJ, Shim JR, Choi BH, Lee JH, et al. Successful defibrotide treatment of a patient with venoocclusive disease after living-donor liver transplantation: a case report. Medicine (Baltimore). 2021;100(25):e26463. PMID: 34160449 https://doi.org/10.1097/MD.0000000000026463; Takamura H, Nakanuma S, Hayashi H, Tajima H, Kakinoki K, Kitahara M, et al. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation. Transplant Proc. 2014;46(10):3523–3535. PMID: 25498084 https://doi.org/10.1016/j.transproceed.2014.09.110; Sanei MH, Schiano TD, Sempoux C, Fan C, Fiel MI. Acute cellular rejection resulting in sinusoidal obstruction syndrome and ascites postliver transplantation. Transplantation. 2011;92(10):1152– 1158. PMID: 21993182 https://doi.org/10.1097/TP.0b013e318234119d; Yamada N, Urahashi T, Ihara Y, Sanada Y, Wakiya T, Okada N, et al. Veno-occlusive disease/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report. Transplant Proc. 2012;44(3):810–813. PMID: 22483502 https://doi.org/10.1016/j.transproceed.2012.01.008; Cesaretti M, Izzo A, Pellegrino RA, Galli A, Mavrothalassitis O. Cold ischemia time in liver transplantation: an overview. World J Hepatol. 2024;16(6):883– 890. PMID: 38948435 https://doi.org/10.4254/wjh.v16.i6.883; Zhang Y, Yan Y, Song B. Noninvasive imaging diagnosis of sinusoidal obstruction syndrome: a pictorial review. Insights Imaging. 2019;10(1):110. PMID: 31748956 https://doi.org/10.1186/s13244-019-0791-x; Dalle JH, Giralt SA. Hepatic venoocclusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22(3):400–409. PMID: 26431626 https://doi.org/10.1016/j.bbmt.2015.09.024; Masek J, Fejfar T, Frankova S, Husova L, Krajina A, Renc O, et al. Transjugular intrahepatic portosystemic shunt in liver transplant recipients: outcomes in six adult patients. Vasc Endovascular Surg. 2023;57(4):373– 378. PMID: 36593684 https://doi.org/10.1177/15385744221149907; Bianco G, Pascale MM, Frongillo F, Nure E, Agnes S, Spoletini G. Transjugular portosystemic shunt for early-onset refractory ascites after liver transplantation. Hepatobiliary Pancreat Dis Int. 2021;20(1):90–93. PMID: 32967815 https://doi.org/10.1016/j.hbpd.2020.09.005; Tripon S, Francoz C, Albuquerque A, Paradis V, Boudjema H, Voitot H, et al. Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia. Transpl Int. 2015;28(2):162–169. PMID: 25267442 https://doi.org/10.1111/tri.12466; Lipi L, Choudhary NS, Dhampalwar S, Kathuria A, Saraf N, Soin AS. Cytomegalovirus duodenitis causing persistent hypoalbuminemia and ascites after liver transplantation. J Clin Exp Hepatol. 2024;14(4):101387. PMID: 38495464 https://doi.org/10.1016/j.jceh.2024.101387; Choudhary NS, Lipi L, Dhampalwar S, Saraf N, Soin AS. A rare cause for persistent ascites after liver transplantation. Indian J Gastroenterol. 2024;43(2):513–514. PMID: 38446348 https://doi.org/10.1007/s12664-02401553-x; Поршенников И.А., Аммосов А.А., Сидоренко А.Б., Павлик В.Н., Быков А.Ю., Саакян Г.С. и др. Сплит-трансплантация печени двум реципиентам по неотложным показаниям: пример и логистика межрегиональной кооперации. Анналы хирургической гепатологии. 2020;25(4):71–84. Porshennikov IA, Ammosov AA, Sidorenko AB, Pavlik VN, Bykov AYu, Saakyan GS, et al. Split liver transplantation in two recipients for urgent indications: an example and logistics of interregional cooperation. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2020;25(4):71–84. (In Russ.). https://doi.org/10.16931/19955464.2020471-84; Гегенава Б.Б., Курносов С.А., Мойсюк Я.Г., Ветшева Н.Н., Аммосов А.А. Экстренное рентгенхирургическое эндоваскулярное лечение раннего нарушения артериального кровотока в печеночном трансплантате. Трансплантология. 2021;13(4):367–381. Gegenava BB, Kurnosov SA, Moysyuk YaG, Vetsheva NN, Ammosov AA. Emergency interventional endovascular treatment for early disorder of arterial blood flow in the liver graft. Transplantologiya. The Russian Journal of Transplantation. 2021;13(4):367–381. (In Russ.). https://doi.org/10.23873/2074-0506-2021-13-4367-381; https://www.jtransplantologiya.ru/jour/article/view/965

Availability: https://www.jtransplantologiya.ru/jour/article/view/965
https://doi.org/10.23873/2074-0506-2025-17-1-41-55

View record from BASE

2

Academic Journal

A CASE OF SUCCESSFUL APPLICATION OF ENDOVASCULAR BLEEDING ARREST TECHNOLOGY IN A PATIENT WITH CIRRHOSIS OF THE LIVER COMPLICATED BY PORTAL HYPERTENSION ; СЛУЧАЙ УСПЕШНОГО ПРИМЕНЕНИЯ ЭНДОВАСКУЛЯРНОЙ ТЕХНОЛОГИИ ОСТАНОВКИ КРОВОТЕЧЕНИЯ У БОЛЬНОГО ЦИРРОЗОМ ПЕЧЕНИ, ОСЛОЖНЕННЫМ ПОРТАЛЬНОЙ ГИПЕРТЕНЗИЕЙ

Authors: Цеймах, Е.А., Макин, А.А, Губаренко, Е.Ю., Арутюнова, А.К., Парфенова, И.Н., Савеленок, И.Д.

Source: POLYTRAUMA; № 4 (2024): декабрь; 68-74 ; ПОЛИТРАВМА / POLYTRAUMA; № 4 (2024): декабрь; 68-74 ; 2541-867X ; 1819-1495

Subject Terms: cirrhosis of the liver, portal hypertension, bleeding from varicose veins of the esophagus and stomach, transjugular intrahepatic portosystemic bypass, цирроз печени, портальная гипертензия, кровотечение из варикозно-расширенных вен пищевода и желудка, трансъюгулярное внутрипеченочное портосистемное шунтирование

File Description: application/pdf

Relation: http://poly-trauma.ru/index.php/pt/article/view/563/821

Availability: http://poly-trauma.ru/index.php/pt/article/view/563

View record from BASE

3

Academic Journal

Idiopathic non-cirrhotic portal hypertension and Budd — Chiari syndrome: focus on the problem

Authors: Antonenko, А. V., Beregova, T. V.

Source: Modern Gastroenterology; № 1 (2019); 119-124
Современная гастроэнтерология; № 1 (2019); 119-124
Сучасна гастроентерологія; № 1 (2019); 119-124

Subject Terms: идиопатическая нецирротическая портальная гипертензия, синдром Бадда — Киари, трансъюгулярное внутрипеченочное портосистемное шунтирование (TIPS), кровотечение из варикозно расширенных вен, ідіопатична нециротична портальна гіпертензія, синдром Бадда — Кіарі, транс'югулярне внутрішньопечінкове портосистемне шунтування (TIPS), кровотеча з варикозно розширених вен, idiopathic non-cirrhotic portal hypertension, Budd — Chiari syndrome, transjugular intrahepatic portosystemic shunt (TIPS), bleeding from varicose veins, 3. Good health

File Description: application/pdf

Access URL: http://sgastro.com.ua/article/view/159796

4

Academic Journal

Efficacy and Safety of Ascites Treatment in Liver Cirrhosis ; Эффективность и безопасность лечения асцита при циррозе печени

Authors: G. A. Ignatenko, T. E. Kugler, G. G. Taradin, I. V. Rakitskaya, A. A. Kaluga, Г. А. Игнатенко, Т. Е. Куглер, Г. Г. Тарадин, И. В. Ракитская, А. А. Калуга

Contributors: The study was performed without external funding. The authors express their gratitude to Elena N. Polyanchikova for her assistance with graphic material, Работа выполнена без спонсорской поддержки. Авторы выражают благодарность Е.Н. Полянчиковой за оказанную помощь в работе с графическим материалом

Source: Safety and Risk of Pharmacotherapy; Том 10, № 2 (2022); 161-175 ; Безопасность и риск фармакотерапии; Том 10, № 2 (2022); 161-175 ; 2619-1164 ; 2312-7821

Subject Terms: ALFA-помпа, ascites, diuretics, paracentesis, liver transplantation, adverse reactions, transjugular intrahepatic portosystemic shunt, Alfapump, асцит, диуретики, нежелательные реакции, парацентез, трансплантация печени, трансъюгулярное внутрипеченочное портосистемное шунтирование

File Description: application/pdf

Relation: https://www.risksafety.ru/jour/article/view/273/550; https://www.risksafety.ru/jour/article/downloadSuppFile/273/244; https://www.risksafety.ru/jour/article/downloadSuppFile/273/246; Ивашкин ВТ, Маевская МВ, Павлов ЧС, Федосьина ЕА, Бессонова ЕН, Пирогова ИЮ, Гарбузенко ДВ. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(4):71–102.; European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417. https://doi.org/10.1016/j.jhep.2010.05.004; Дядык АИ, Куглер ТЕ, Маловичко ИС, Яровая НФ, Ракитская ИВ. Принципы диуретической терапии при лечении больных циррозом печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(5):48–56.; Gordon FD. Ascites. Clin Liver Dis. 2012;16(2):285–99. https://doi.org/10.1016/j.cld.2012.03.004; Zhao R, Lu J, Shi Y, Zhao H, Xu K, Sheng J. Current management of refractory ascites in patients with cirrhosis. J Int Med Res. 2018;46(3):1138–45. https://doi.org/10.1177/0300060517735231; Pedersen JS, Bendtsen F, Møller S. Management of cirrhotic ascites. Ther Adv Chronic Dis. 2015;6(3):124– 37. https://doi.org/10.1177/2040622315580069; Reynolds TB. Ascites. Clin Liver Dis. 2000;4(1):151– 68. https://doi.org/10.1016/s1089-3261(05)70101-x; Hasan M, Akbar SMF, Al Mahtab M, Kumar PJ. Textbook of hepato-gastroenterology. 1st edition. New Delhi: Jaypee Brothers Medical Publishers; 2015.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258–66. https://doi.org/10.1053/jhep.2003.50315; Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol. 2019;25(28):3738–52. https://doi.org/10.3748/wjg.v25.i28.3738; Arroyo V, Fernandez J. Relationship between systemic hemodynamics, renal dysfunction, and fluid retention in cirrhosis. Clin Liver Dis (Hoboken). 2013;2(3):120–2.; Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol. 2010;53(6):1135–45.; Bernardi M, Domenicali M. The renin-angiotensin-aldosterone system in cirrhosis. In: Ginès P, Arroyo V, Rodés J, Schrier RW, eds. Ascites and renal dysfunction in liver disease: pathogenesis, diagnosis and treatment. Malden: Blackwell; 2005. P. 43–54.; Ginès P, Cárdenas A, Schrier RW. Liver disease and the kidney. In: Schrier RW, ed. Diseases of the kidney and urinary tract. Philadelphia: Lippincott Williams & Wilkins; 2007. P. 2179–2205.; Arroyo V, Terra C, Ginès P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol. 2007;46(5):935–46. https://doi.org/10.1016/j.jhep.2007.02.001; Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63(5):1272–84. https://doi.org/10.1016/j.jhep.2015.07.004; Neong SF, Adebayo D, Wong F. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Expert Rev Gastroenterol Hepatol. 2019;13(4):293–305. https://doi.org/10.1080/17474124.2018.1555469; Dirchwolf M, Podhorzer A, Marino M, Shulman C, Cartier M, Zunino M, et al. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. Cytokine. 2016;77:14–25. https://doi.org/10.1016/j.cyto.2015.10.006; Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, et al. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Aliment Pharmacol Ther. 2018;47(7):980–8. https://doi.org/10.1111/apt.14522; Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142–53. https://doi.org/10.1016/s0168-8278(00)80201-9; Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2019;114(1):40–7. https://doi.org/10.1038/s41395-018-0185-6; Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, et al. Improvement in quality of life and decrease in large-volume paracentesis requirements with the automated low-flow ascites pump. Liver Transpl. 2020;26(5):651–61. https://doi.org/10.1002/lt.25724; Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int. 2018;12(Suppl 1):122–34. https://doi.org/10.1007/s12072-017-9815-0; Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol. 2011;17(10):1237–48. https://doi.org/10.3748/wjg.v17.i10.1237; Aithal GP, Palaniyappan N, China L, Harmala S, Macken L, Ryan JM, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9–29. https://doi.org/10.1136/gutjnl-2020-321790; Tzamaloukas AH, Malhotra D, Rosen BH, Raj DSC, Murata GH, Shapiro JI. Principles of management of severe hyponatremia. J Am Heart Assoc. 2013;2(1):e005199. https://doi.org/10.1161/jaha.112.005199; Дядык АИ, Тарадин ГГ, Сулиман ЮВ, Зборовский СР, Меркурьев ВИ. Диуретики при хронической болезни почек. Архивъ внутренней медицины. 2020;10(1):10–20. https://doi.org/10.20514/2226-6704-2020-10-1-10-20; Kasztelan-Szczerbinska B, Cichoz-Lach H. Refractory ascites — the contemporary view on pathogenesis and therapy. Peer J. 2019;7:e7855. https://doi.org/10.7717/peerj.7855; Guo TT, Yang Y, Song Y, Ren Y, Liu ZX, Cheng G. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis. J Dig Dis. 2016; 17(1):11–9. https://doi.org/10.1111/1751-2980.12304; Hanafy AS, Hassaneen AM. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival. Eur J Gastroenterol Hepatol. 2016;28(12):1455– 61. https://doi.org/10.1097/meg.0000000000000743; Lenaerts A, Codden T, Meunier JC, Henry JP, Ligny G. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology. 2006;44(4):844–9. https://doi.org/10.1002/hep.21355; Yang YY, Lin HC, Lee WP, Chu CJ, Lin MW, Lee FY, et al. Association of the G-protein and α2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial. Gut. 2010;59(11):1545–53. https://doi.org/10.1136/gut.2010.210732; EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60. https://doi.org/10.1016/j.jhep.2018.03.024; Zhou X, Tripathi D, Song T, Shao L, Han B, Zhu J, et al. Terlipressin for the treatment of acute variceal bleeding: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(48):e13437. https://doi.org/10.1097/md.0000000000013437; Colle I, Laterre PF. Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Rev Gastroenterol Hepatol. 2018;12(2):173–88. https://doi.org/10.1080/17474124.2018.1417034; Møller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000;20(1):51–9. https://doi.org/10.1034/j.1600-0676.2000.020001051.x; Krag A, Møller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology. 2007;46(6):1863– 71. https://doi.org/10.1002/hep.21901; Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites. Nephrol Dial Transplant. 2005;20(8):1623–9. https://doi.org/10.1093/ndt/gfh871; Zhang X, Wang SZ, Zheng JF, Zhao WM, Li P, Fan CL, et al. Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients. World J Gastroenterol. 2014;20(32):11400–5. https://doi.org/10.3748/wjg.v20.i32.11400; Bellos I, Kontzoglou K, Psyrri A, Pergialiotis V. Tolvaptan response improves overall survival in patients with refractory ascites: a meta-analysis. Dig Dis. 2020;38(4):320–8. https://doi.org/10.1159/000503559; Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Rep. 2019;2(1):100063. https://doi.org/10.1016/j.jhepr.2019.12.001; Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease. Gut. 2012;61(7):967–9. https://doi.org/10.1136/gutjnl-2011-301348; Brito-Azevedo A. Diuretic window hypothesis in cirrhosis: Changing the point of view. World J Gastroenterol. 2019;25(26):3283–90. https://doi.org/10.3748/wjg.v25.i26.3283; Chirapongsathorn S, Valentin N, Alahdab F, Krittanawong C, Erwin PJ, Murad MH, Kamath PS. Nonselective β-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(8):1096–104.e9. https://doi.org/10.1016/j.cgh.2016.01.012; De Gottardi A, Thévenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009;7(8):906–9. https://doi.org/10.1016/j.cgh.2009.05.004; Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol. 2002;37(4):463–70. https://doi.org/10.1016/s0168-8278(02)00208-8; Hung A, Garcia-Tsao G. Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int. 2018;38(8):1437–41. https://doi.org/10.1111/liv.13712; Kim JH. What we know about paracentesis induced circulatory dysfunction? Clin Mol Hepatol. 2015;21(4):349– 51. https://doi.org/10.3350/cmh.2015.21.4.349; Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55(4):1172–81. https://doi.org/10.1002/hep.24786; Bernardi M, Caraceni P, Navickis RJ. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis? Expert Rev Gastroenterol Hepatol. 2017;11(3):191–2. https://doi.org/10.1080/17474124.2017.1275961; Di Pascoli M, Fasolato S, Piano S, Bolognesi M, Angeli P. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. Liver Int. 2019;39(1):98–105. https://doi.org/10.1111/liv.13968; Kozaki K, IInuma M, Takagi T, Fukuda T, Sanpei T, Terunuma Y, et al. Cell-free and concentrated as cites reinfusion therapy for decompensated liver cirrhosis. Ther Apher Dial. 2016;20(4):376–82. https://doi.org/10.1111/1744-9987.12469; Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014;20(10):2704–14. https://doi.org/10.3748/wjg.v20.i10.2704; Allegretti AS, Ortiz G, Cui J, Wenger J, Bhan I, Chung RT, et al. Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis. Am J Kidney Dis. 2016;68(3):381–91. https://doi.org/10.1053/j.ajkd.2016.02.041; Bercu ZL, Fischman AM, Kim E, Nowakowski FS, Patel RS, Schiano TD, et al. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stentgrafts. AJR Am J Roentgenol. 2015;204(3):654–61. https://doi.org/10.2214/ajr.14.12885; Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology. 2017;152(1):157– 63. https://doi.org/10.1053/j.gastro.2016.09.016; Miraglia R, Maruzzelli L, Tuzzolino F, Petridis I, D’Amico M, Luca A. Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFEcovered stents. Radiology. 2017;284(1):281–8. https://doi.org/10.1148/radiol.2017161644; Rudler M, Mallet M, Sultanik P, Bouzbib C, Thabut D. Optimal management of ascites. Liver Int. 2020; 40(Suppl 1):128–35. https://doi.org/10.1111/liv.14361; Sarwar A, Zhou L, Novack V, Tapper EB, Curry M, Malik R, Ahmed M. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology. 2018;67(2):690–9. https://doi.org/10.1002/hep.29354; Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, et al. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013;58(5):922–7. https://doi.org/10.1016/j.jhep.2012.12.020; Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, et al. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017;46(10):981–91. https://doi.org/10.1111/apt.14331; Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, et al. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. J Hepatol. 2017;67(5):940–9. https://doi.org/10.1016/j.jhep.2017.06.010; Lepida A, Marot A, Trépo E, Degre D, Moreno C, Deltenre P. Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites. Aliment Pharmacol Ther. 2019;50(9):978–87. https://doi.org/10.1111/apt.15502; Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, et al. Improvement in quality of life and de crease in large-volume paracentesis requirements with the automated low-flow ascites pump. Liver Transpl. 2020;26(5):651–61. https://doi.org/10.1002/lt.25724; Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol. 2009;15(1):67–80. https://doi.org/10.3748/wjg.15.67; https://www.risksafety.ru/jour/article/view/273

Availability: https://www.risksafety.ru/jour/article/view/273
https://doi.org/10.30895/2312-7821-2022-10-2-161-175

View record from BASE

5

Report

СЛУЧАЙ УСПЕШНОГО ПРИМЕНЕНИЯ ЭНДОВАСКУЛЯРНОЙ ТЕХНОЛОГИИ ОСТАНОВКИ КРОВОТЕЧЕНИЯ У БОЛЬНОГО ЦИРРОЗОМ ПЕЧЕНИ, ОСЛОЖНЕННЫМ ПОРТАЛЬНОЙ ГИПЕРТЕНЗИЕЙ

Subject Terms: цирроз печени, transjugular intrahepatic portosystemic bypass, кровотечение из варикозно-расширенных вен пищевода и желудка, трансъюгулярное внутрипеченочное портосистемное шунтирование, cirrhosis of the liver, портальная гипертензия, portal hypertension, bleeding from varicose veins of the esophagus and stomach

6

Report

МАЛОИНВАЗИВНЫЕ МЕТОДЫ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ КРОВОТЕЧЕНИЙ ИЗ ВАРИКОЗНО РАСШИРЕННЫХ ВЕН ЖЕЛУДКА У БОЛЬНЫХ С СИНДРОМОМ ПОРТАЛЬНОЙ ГИПЕРТЕНЗИИ (обзор литературы)

Subject Terms: transjugular intrahepatic portosystemic shunting, balloon-occluded retrograde transvenous obliteration, пищеводно-желудочное кровотечение, ретроградная трансвенозная облитерация с баллонной окклюзией, эндоскопическое лигирование, gastroesophageal bleeding, трансъюгулярное внутрипеченочное портосистемное шунтирование, endoscopic band ligation, эндоскопическая склеротерапия, варикозное расширение вен желудка, gastric varices, endoscopic sclerotherapy, 3. Good health

7

Academic Journal

TRANSJUGULAR INTRA HEPATIC PORTOSISTEMNY SHUNTING: METHOD OF CORRECTION OF INTRA HEPATIC PORTAL HYPERTENSIA ; ТРАНСЪЮГУЛЯРНОЕ ВНУТРИПЕЧЕНОЧНОЕ ПОРТОСИСТЕМНОЕ ШУНТИРОВАНИЕ: МЕТОД КОРРЕКЦИИ ВНУТРИПЕЧЕНОЧНОЙ ПОРТАЛЬНОЙ ГИПЕРТЕНЗИИ

Authors: N. G. Sарrоnоvа, M. I. Polyak, E. V. Коsоvtsеv, Н. Г. Сапронова, М. И. Поляк, Е. В. Косовцев

Source: Medical Herald of the South of Russia; № 2 (2014); 79-83 ; Медицинский вестник Юга России; № 2 (2014); 79-83 ; 2618-7876 ; 2219-8075 ; 10.21886/2219-8075-2014-2

Subject Terms: трансъюгулярное внутрипеченочное портосистемное шунтирование, liver cirrhosis, TIPS, цирроз печени

File Description: application/pdf

Relation: https://www.medicalherald.ru/jour/article/view/179/180; Анисимов А.Ю., Туишев Р.И., Балашова О.В. Настоящее и будущее хирургии портальной гипертензии//Казанский медицинский журнал. -2004. -Т.85, №2. -С.99-102.; Бобров А.Н., Белякин С.А., Плюснин С.В. Этиологическая структура циррозов печени по результатам пятнадцатилетнего наблюдения//Вестник Российской военно-медицинской академии. -2011. -№1(33). -С.76-80.; Mieles L.A., Esquinel C.O., Van Thiel D.H. et al. Liver transplantation for tyrosinemia: a review of 10 cases from the University of Pittsburgh//Dig. Dis. Sci. -1990. -N 35. -P.153.; Семенова В.В. Дифференцированный подход к хирургическому лечению портальной гипертензии//Гепатология. -2007. -№5. -С.12-15.; Ерамишанцев А.К. Хирургическое лечение портальной гипертензии//Российский журнал гастроэнтерологии, гепатологии и колопроктологии. -1997. -№2. -С.72-75.; Ханевич М.Д., Кошевой А.П. Лечение при язвенных кровотечениях у больных с циррозом печени и портальной гипертензией//Вестник хирургии. -2000. -Т. 159, №2. -С.27-30.; Шапошников А.В. Асцит: современные подходы к классификации и лечению//Российский журнал гастроэнтерологии, гепатологии и колопроктологии. -2001. -№3. -С.19-23.; Котив Б.Н., Дзидзава И.И., Кочаткова А.А. и др. Роль портокавального шунтирования в эру трансплантации печени//Трансплантология. -2009. -№1. -С.34-38.; TIPS/ТИПС (трансюгулярное внутрипеченочное порто-системное шунтирование) и лечение варикозных пищеводно-желудочных кровотечений/Ю.В.Хоронько, М.Ф.Черкасов, М.И.Поляк, Ю.Е.Баранов. -М.: Фарм-Синтез, 2013. -242 с.; Ярема И.В., Омаров И.М. Хирургическая коррекция гемо-и лимфообращения при циррозе печени//Вестник хирургии. -2000. -Т.159, №6. -С.17-19.; https://www.medicalherald.ru/jour/article/view/179

Availability: https://www.medicalherald.ru/jour/article/view/179
https://doi.org/10.21886/2219-8075-2014-2-79-83

View record from BASE

8

Academic Journal